Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
242 participants
OBSERVATIONAL
2018-01-01
2020-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pressure Support Ventilation Versus Neurally Adjusted Ventilatory Assist in Difficult to Wean Pediatric Patients
NCT04360590
A Study on Ventilator-associated Pneumonia as a Risk for Nosocomial Infection in Mechanically Ventilated Neonates In NICU of Assiut University Children Hospital (Nicu Eta)
NCT03310840
The Effectiveness of the Modified Bundle in the Prevention of VAP.
NCT04038814
Treatment of Ventilator Associated Pneumonia in Pediatric Intensive Care Unit
NCT03294837
Ventilator Associated Pneumonia Care Bundle Prevention on Internship Students' Knowledge and Clinical Performance
NCT06090019
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Retrospective control group
Patients admitted in our PICU before the implementation of the protocol for VAP prevention (from 01/01/2016 to 12/31/2017)
Evaluation of VAP incidence before the protocol introduction
evaluation of VAP incidence in our pediatric population of intensive care patients before the implementation of the protocol for VAP prevention
Prospective group
Patients admitted to our PICU since the VAP bundle has been introduced in the clinical practice (from 01/01/2018)
Measures for the VAP prevention in the PICU
Oral hygiene care (i.e chlorhexidine swab); clean and dry ventilator circuits; head positioning at 45 degrees.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Measures for the VAP prevention in the PICU
Oral hygiene care (i.e chlorhexidine swab); clean and dry ventilator circuits; head positioning at 45 degrees.
Evaluation of VAP incidence before the protocol introduction
evaluation of VAP incidence in our pediatric population of intensive care patients before the implementation of the protocol for VAP prevention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients receiving mechanical ventilation for more than 48 hours
Exclusion Criteria
* pregnancy
* previous endotracheal antibiotic therapy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ilaria Vitali
UNKNOWN
Antonio Maria Dell Anna
UNKNOWN
Leonardo Dassatti
UNKNOWN
Giuseppe Bello
UNKNOWN
Giorgio Conti
UNKNOWN
Antonio D Addona
UNKNOWN
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Orazio Genovese
Medical Doctor, pediatric intensive care unit
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giorgio Conti, MD
Role: STUDY_CHAIR
Università Cattolica del Sacro Cuore; Fondazione Policlinico Universitario Agostino Gemelli; IRCCS
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fondazione Policlinico Universitario Agostino Gemelli
Roma, RM, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Orazio Genovese, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1855
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.